The increasing acceptance that proteins may exert multiple functions in the cell brings with it new analytical challenges that will have an impact on the field of proteomics. Many proteomics workflows begin by destroying information about the interactions between different proteins, and the reduction of a complex protein mixture to constituent peptides also scrambles information about the combinatorial potential of post-translational modifications. To bring the focus of proteomics on to the domain of protein moonlighting will require novel analytical and quantitative approaches.
Introduction
Although there is continuing debate over the precise definition of protein moonlighting, it can be taken to encompass a protein that exerts multiple activities, leading to discrete functional roles, within a single polypeptide chain. This excludes gene duplication followed by divergent evolution, splice variants and protein isoforms, but encompasses posttranslational variants and spatial and temporal variation in expression of a single gene product [1] [2] [3] [4] [5] . Thus protein moonlighting implies a change in structure that leads to a new biological capability, an association with a new binding partner that modulates activity to encompass an additional or distinct capacity, or a physical translocation to a different biological space or compartment where a protein may manifest its presence differently. Furthermore, a shift in post-translational state might be induced by a reversible (e.g. phosphorylation) or an irreversible (e.g. proteolytic) change in the protein, either of which could confer a new capability. This complexity of post-translational states in proteins has been referred to as the 'protein speciation' problem, and is a major challenge for analytical protein science [6] [7] [8] .
The emergent technology and philosophy of proteomics is driven in part by the need to pursue the increasingly pervasive and far-reaching methodologies of genomics and transcriptomics. To paraphrase Arthur Kornberg, DNA and RNA provide the script, but it is proteins that are the actors [9] and this is never more significant than in the elucidation of protein roles as 'moonlighting' entities. To extend the analogy, an actor need not be confined to a single role, and it is a measure of capability and versatility if the roles can extend from the biomolecular analogues of intense Shakespearean drama to soap operas! At the same time, the multiplicity of roles can impose constraints in protein evolution, and selection pressures can be antagonistic. For example, a protein that plays a natural function in a host organism, yet which is also subverted into assistance of an infectious agent is subject to opposing selection pressures, and it is difficult to see this as anything other than a transient antagonistic state that should rapidly achieve resolution through natural selection. By contrast, other proteins can exert distinct but complementary functions: the mouse urinary protein that is both a pheromone in its own right and also acts as a carrier and slow release binder for a second low-molecular-mass volatile pheromone that attracts the receiver animal to the protein, whereupon it exerts a different and more profound effect [10] [11] [12] [13] . Although these functions are complementary, they impose constraints on different parts of the molecule (the interior cavity-lining residues and the exterior putative receptor-interacting surface) and the selection pressures on these regions of the protein sequence are likely to differ. Yet, at the same time, both functions are inextricably interlinked, and it seems reasonable to assume that the selection pressures, in the context of chemical communication, are unidirectional and driven by both roles that might be under different selection pressure in other species.
Proteomics in the study of protein moonlighting
Proteomics offers the potential to resolve spatial, temporal and structural differences between the moonlighting roles of proteins and to identify protein-protein interactions in the pursuit of alternative binding partners, leading to new functions [14] . At present, proteomics is moving from discovery-based analytical workflows to a formally quantitative methodology, and the introduction of a quantitative perspective can undoubtedly add a new insight into the behaviour of proteins in 'protein space'. However, many proteomics workflows ('bottom-up' [15] [16] [17] ) commence with a proteolytic digestion (usually, but not obligatorily, trypsin) and thus, at an early stage in analysis, not only are protein-protein interactions destroyed, but also the connectivity between the sites of post-translational Soluble proteins of the yeast S. cerevisiae were fractionated using a mixed-bed ion-exchange chromatographic system. Each fraction was then subjected to bottom-up discovery proteomics, and the abundances of individual proteins were determined by label-free methods (b). The entire dataset, a table of abundance values for approximately 1000 proteins across 30 fractions, was subjected to hierarchical clustering across protein and chromatographic fractions (a). A close-up of the clustering analysis (c) reveals clusters of co-eluting proteins, some of which reflect association of native-state quaternary structures, but which might also reflect associations between proteins consistent with new moonlighting functions. Whereas some proteins elute with very sharp profiles, others elute over a very broad range of fractions. Inasmuch as the sharp protein profiles reflect the chromatographic quality that can be attained, the broadly eluting proteins may well reflect post-translational heterogeneity or association with multiple binding partners.
Figure 2 Label-free quantification to determine subunit abundance
From the mixed-bed ion-exchange separation referred to in Figure 1 , the elution profiles for the label-free abundance of the 14 subunits of the core 20S proteasome complex were recovered and plotted as an elution profile (a). For a second replicate of the experiment, equivalent data were recovered and the label-free abundances of the 14 subunits were correlated for the two experiments (b).
variants is lost; for example, evidence may be accrued for phosphorylation at two positions in a primary sequence (A, B), but it is not possible to discern the relative proportions of the four combinatorial possibilities: [A, B], [phosphoA, phosphoB], [A, phosphoB] and [phosphoA, B] by bottomup approaches. Given that post-translational space might be a key level at which moonlighting becomes apparent, it is clear to see that bottom-up approaches are of limited value, and should perhaps be applied late in the analytical workflow when the data required are the identities and quantities of specific proteins.
'Top-down' proteomics, in which the analyte comprises single proteins or mixtures of proteins, can be equally challenging [15, 17, 18] . In electrospray ionization, protein molecules are multiply and variably protonated such that even a single species yields a complex mass spectrum. This mass spectrum can then be deconvoluted to recover the mass of the protein. It is also possible to select one of the charge variants and subject this to further high-energy decomposition to generate series of ions that can recapitulate, in part, the primary sequence of the protein. However, because each protein can generate tens or hundreds of differently charged ions, and these are presented to the mass analyser at the same time, top-down approaches are not readily applied to complex proteome samples, because of the sheer analytical complexity of the signal, and the difficulty of deconvoluting such a complex series of ions. Thus top-down approaches are predominantly applied to single proteins (with or without their attendant posttranslational decoration) or simple mixtures. For protein mixtures of modest complexity, it is feasible to deconvolute the multiply charged and overlapping mass spectra and build a 'mass map' of the mixture [19] . For example, we have applied this approach to the major soluble proteins from skeletal muscle and were able to assign the deconvoluted masses of more than ten proteins, predominantly glycolytic. Interestingly, the correlation between predicted and observed masses required that post-translational changes, particularly loss of N-terminal methionine and subsequent acetylation, be invoked. Even after this adjustment, some mass discrepancies remained unexplained [20] .
More complex protein mixtures are not readily amenable to top-down proteomics, but the approach can be applied to simplified protein mixtures. If proteins engage in moonlighting by virtue of relatively tight association with protein binding partners, it might also be feasible to discern such associations by virtue of chromatographic co-elution under non-denaturing conditions. To illustrate this, we separated soluble proteins from Saccharomyces cerevisiae using mixed-bed ion-exchange chromatography. Each fraction (30 in total) was then subjected to bottom-up proteomics to obtain the identities and a measure of relative abundance, the latter derived by label-free quantification (Figure 1) . From this study, we obtained the identity, quantification and mixed-bed elution position for many hundreds of proteins. The matrix of data comprising protein identity, and the label-free quantification obtained for that protein in each fraction was then processed by hierarchical clustering. As might be anticipated, the strongest clustering was obtained for proteins that co-eluted in single fractions or peaks, but other clusters also reflected the appearance of a protein more broadly distributed across the elution profile. As anticipated, tightly associated complexes (such as the subunits of the 20S core proteasome particle) co-eluted in a tight single fraction peak (Figure 2) .
A second aspect of this approach to the study of protein moonlighting is the need for a quantitative assessment of the distribution of each protein of interest. Two commonly adopted approaches to absolute protein quantification are based on the signal intensities of the tryptic peptides that are analysed. These are label-free quantification, based on the inherent signal intensity of individual tryptic peptides, and those based on quantification of a selected analyte peptide by reference to a stable isotope-labelled standard.
Label-free quantification does require a good concordance between the abundance of each protein and the abundance of the tryptic fragments that are generated in a proteomics workflow. Whereas this may generally hold [21, 22] , care should be exercised in the analysis of protein stoichiometry and relative abundances. For example, in the mixed-bed ionexchange chromatography experiment referred to above, the 20S proteasome subunits eluted in a single clean peak in each of five replicated studies. There was no evidence for the presence of any of the 14 20S proteasome subunits in any other fraction. Assuming that there were, in fact, no 20S subunits in any other fraction, it seemed reasonable to conjecture that the ion-exchange peak reflected intact 20S particles, and that therefore each subunit should be present at equimolar stoichiometry. Comparison of the label-free quantification profiles for each of the subunits reveals the limitation of the method (Figure 2) . If the assumption of a unitary stoichiometry is valid, then the value of a labelfree approach for subunit quantification must be treated with caution: the label-free quantification data deviate significantly from the expected equimolar ratio. Moreover, the relative abundance of each subunit was replicated across multiple chromatographic runs, suggesting that this is inherently due to the peptides derived from each protein, their behaviour within the mass spectrometer and the label-free quantification algorithms. Label-free quantification has greatest value in the comparison of abundances of individual proteins (relative quantification), but care may need to be applied if used for absolute quantification.
More accurate quantification would be obtained by the use of stable-isotope-labelled internal standards [23] . In proteomics, one or more peptides are used as surrogates for the protein, as it is assumed that the protein is fully digested and thus each peptide should show a molar equivalence to the parent protein [24] . For example, an unknown quantity of the natural peptide LAGNTSAAFVCANVR could be quantified by reference to a known quantity of the peptide LAGNTSAAFVCANV[ 13 C 6 ]R, in which six carbon atoms of the C-terminal arginine residue are replaced with 13 C atoms, rendering a standard that is 6 Da heavier than the corresponding analyte [25] [26] [27] . Using the same labelling strategy, but with [ 13 C 6 ]lysine as the label, means that all tryptic peptides could be quantified. The stableisotope-labelled peptides can be made by chemical synthesis [28] or can be generated by concatenation of multiple standard peptides, derived from different proteins into novel concatamers, QconCATs, that are expressed from novel genes designed in silico [29] [30] [31] [32] . QconCATs have been used to quantify complete pathways or functional groups of proteins, including the glycolytic pathway [22] and the chaperone network [21] in S. cerevisiae. The dynamic range of such proteins is remarkable; some of the glycolytic enzymes are present at several million copies per cell (e.g. fructose-1,6-bisphosphate aldolase), whereas others are present at just a few thousand copies per cell (Figure 3) . Similarly, the chaperone family ranges from about one-third of a million copies per cell (Hsp12, Ssa1) to just a few hundred copies or fewer. The substantial variation in protein abundance reflects a composite outcome of catalytic efficiency, flux demand and overall workload, but given such a broad dynamic range, it is perhaps unsurprising to note that moonlighting functions are often linked to the abundant proteins in the cell. Not only is their concentration high, but also the part of the protein pool that could be abstracted for other roles would conceivably make a very limited demand on the total pool.
It is likely that additional moonlighting roles will be ascribed to new proteins as our ability to perform sensitive and selective proteomic analyses develops. It is now possible, for example, to identify the entire S. cerevisiae proteome (over 4000 proteins) in a 1 h analysis [33] . Advances in MS-based identification of binding partners [34] [35] [36] [37] , the ability to quantify the intracellular stability of proteins (potentially, a role-dependent parameter) [38] [39] [40] [41] and the capability to discern post-translational subtlety with ever increasing depth [42] all suggest that these technologies will play an increasingly important role in characterization of the 'moonlighting proteome' [43] . Yet, we should also acknowledge that all of the current approaches require cellular disruption and dilution, and a true examination of subtle moonlighting roles will require that we also develop advanced methods to explore proteins in situ.
